2007 American Society Of Gene Therapy Meeting
The American Society of Gene Therapy (ASGT) is pleased to invite members of the press to a media only event designed to highlight some of the latest and most promising developments in gene therapy products and related technologies.
WHERE
Grand Hyatt Seattle - Menzies Room
WHEN
Thursday, May 31, 2007, 7:00 - 9:00 pm (reception at 6:30 pm)
WHY
Several children born with "bubble-boy disease" caused by ADA deficiency have been cured by gene therapy without major side effects and researchers have ameliorated a growing list of disease conditions in animals including diabetes, arthritis, heart disease and cancer. Some of these gene therapy treatments are now in advanced stages of clinical trials.
WHO
Leading scientists in the fields of cancer, arthritis, infectious diseases, and childhood blindness will discuss their research and progress toward bringing these promising gene therapy technologies and products to the clinic.
Speakers include:
* Theodore Friedmann, M.D
* Philip J. Mease, M.D.
* John Rossi, Ph.D.
* Joseph C. Glorioso III , Ph.D.
* Kristen M. Hege, M.D.
* Jean Bennett, M.D., Ph.D.
For further information, including speaker biographies, go to http://www.asgt.org/am07/media_program
AMERICAN SOCIETY OF GENE THERAPY TO HOST "NOVEL TECHNOLOGIES TO ADVANCE GENE TRANSFER APPLICATIONS" PRESS CONFERENCE AT 10th ANNUAL MEETING
WHAT
The American Society of Gene Therapy (ASGT) is pleased to invite media to a lunch and press conference designed to answer your questions about the most newsworthy abstracts presented at the 2007 Annual Meeting.
To gain access to the 10th Annual Meeting of the American Society of Gene Therapy, journalists and medical/science writers must provide the information found on the ASGT Media Registration form. The registration fee for working media representatives is waived. Media credentials must be presented on-site in the Press Room in order to receive your press badge. Those registering as press must represent the editorial staff. Advertising or marketing representatives will not be registered as press. A press room with interview space, computers, modem lines, telephone and fax services will also be available for on-site for media representatives.
Representatives of the following media types will be registered:
* General circulation newspapers, magazines, or wire services
* Medical or health care publications
* Broadcast media
* Web site writers
WHERE
Washington State Convention & Trade Center - Room 604 (Press Room)
WHEN
Friday, June 1, 2007, 12:15 - 1:15 pm (lunch will be served)
WHO
Speakers and Abstracts Include:
Understanding and Exploiting Endogenous microRNA Regulation for Controlling Gene Expression
Luigi Naldini, MD, PhD
Telethon Institute for Gene Therapy, San Raffaele Institute
Efficient Gene Correction and Targeted Gene Addition in Human Stem Cells Using Engineered Zinc Finger Nucleases and Integrase-Defective Lentiviral Vectors
Luigi Naldini, MD, PhD
Telethon Institute for Gene Therapy, San Raffaele Institute
Insulin Replacement Gene Therapy for Type 1 Diabetes
Anthony T. Cheung
R&D, enGene, Inc.
CNS Viral Vector Delivery Under Real-Time Imaging Control
Krystof S. Bankiewicz, MD, PhD
Neurological Surgery, University of California, San Francisco
The press conference will be moderated by:
Kenneth Cornetta, MD
Indiana University
ADDITIONAL SESSIONS OF INTEREST AT AMERICAN SOCIETY OF GENE THERAPY 10th ANNUAL MEETING
GEORGE STAMATOYANNOPOULOS LECTURE
Thursday, May 31, 2007
8:00 a.m. - 9:15 a.m.
Speaker:
Judah Folkman, MD
Rationale fo Anti-Angiogenic Gene Therapy
The presentation of Excellence in Research awards will also take place at this lecture.
PRESIDENTIAL SYMPOSIUM
Friday, June 1, 2007
3:00 p.m. - 5:15 p.m.
Speaker:
Cynthia Kenyon, PhD
From Worms to Mammals: Genes that Control the Rate of Aging
The top four abstracts from the 10th Annual Meeting will also be presented at this symposium.
10TH ANNIVERSARY SYMPOSIUM
Saturday, June 2, 2007
2:00 p.m. - 5:00 p.m.
Speakers:
Prof. Sir David Weatherall, MD
The Phenotypic Diversity of Monogenic Disease: A Problem for Experimental Therapies
Maria Grazia Roncarolo, MD, PhD
Gene Therapy for Immuno Deficiency Diseases: From Basic Discoveries to Cure
Malcolm K. Brenner, MD, PhD
Implementing Gene Therapies for Complex Disorders
David Baltimore, PhD
Gene Therapy for Cancer and Infectious Diseases
----------------------------
Article adapted by Start Sanatate from original press release.
----------------------------
Seattle is a unique, vibrant destination. We hope you will join us for an exciting 10th Annual Meeting!
American Society of Gene Therapy
555 East Wells St., Suite 1100
Milwaukee, WI 53202
Contact: Meghan Arnold
American Society of Gene Therapy
2007 societãþii americane de gene de terapie pentru intalniri - 2007 American Society Of Gene Therapy Meeting - articole medicale engleza - startsanatate